Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-24T20:32:09.962Z Has data issue: false hasContentIssue false

Psychiatric comorbidity among patients attending an addiction treatment center in Morocco

Published online by Cambridge University Press:  01 September 2022

A. Jelti*
Affiliation:
Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Department Of Psychiatry, Oujda, Morocco
F. Kennab
Affiliation:
Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Department Of Psychiatry, Oujda, Morocco
F. N’Sabi
Affiliation:
Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Department Of Psychiatry, Oujda, Morocco
B. Oneib
Affiliation:
Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Department Of Psychiatry, Oujda, Morocco
F. Elghazouani
Affiliation:
Mohammed VI University Hospital, Faculty of Medicine and Pharmacy, University Mohammed Premier, Department Of Psychiatry, Oujda, Morocco
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The comorbidity between psychiatric disorders and substance use disorders is more and more common in daily clinical practice. However, only few studies have adressed this subject in north african patients.

Objectives

The main objective of our study was the estimation of the prevalence and patterns of psychiatric co-morbidities in substance users seeking care.

Methods

Our work consisted of a cross-sectional study of a sample of patients attending outpatient substance use treatment at the addiction center in Oujda, Morocco. A hetero-questionnaire was used to collect sociodemographic data and patient history, DSM-IV criteria to assess substance abuse and dependence, and the Mini-International Neuropsychiatric Interview [MINI] to assess psychiatric comorbidities.

Results

Our study involved 100 patients, with a male predominance (89% of users). The main substances used in the last 12 months were tobacco (78%), followed by cannabis (74%), alcohol (50%), and benzodiazepines (44%). Psychiatric comorbidity was identified in 71% of the users, 51% of whom had a depressive disorder, 35% an anxiety disorder and 10% a gambling disorder. The dependence on the substance that initially motivated the consultation was higher in patients with psychiatric comorbidity (p=0.033). The post-traumatic stress disorder was significantly associated with the presence of alcohol dependence (p=0.028). The presence of benzodiazepine dependence (p=0.025) and abuse of cocaine (p=0.028) and Ecstasy (p=0.000) were significantly associated with suicide risk.

Conclusions

Our study found a high prevalence of psychiatric comorbidities among substance users seeking treatment, this should prompt clinicians to pay particular attention to this issue in order to adapt and improve their management.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.